Heart Test Laboratories (NASDAQ:HSCS) Releases Earnings Results, Beats Expectations By $0.03 EPS

Heart Test Laboratories (NASDAQ:HSCS) released its earnings results on Monday. The company reported ($2.27) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.30) by $0.03, Zacks reports.

Heart Test Laboratories Price Performance

Shares of Heart Test Laboratories stock traded up $0.08 during trading hours on Monday, reaching $3.85. 26,565 shares of the company’s stock were exchanged, compared to its average volume of 131,480. Heart Test Laboratories has a 1 year low of $2.36 and a 1 year high of $18.50. The company has a market capitalization of $3.52 million, a P/E ratio of -0.18 and a beta of 3.23. The business has a fifty day moving average of $3.26 and a two-hundred day moving average of $3.83. The company has a quick ratio of 4.02, a current ratio of 4.49 and a debt-to-equity ratio of 0.08.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets reaffirmed a “buy” rating and set a $15.00 target price on shares of Heart Test Laboratories in a report on Monday, September 23rd.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.